DGAP-Adhoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Munich Re resolves share buy-back
2022. február 22., kedd, 13:25
DGAP-Ad-hoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München / Key word(s): Share Buyback In the period between completion of the 2022 Annual General Meeting and the 2023 Annual General Meeting, Munich Re intends to buy back shares for a maximum value of €1bn. On the basis of the authorisation granted by the Annual General Meeting on 29 April 2020 or a future authorisation, and with the approval of the Supervisory Board, represented by the Standing Committee, Munich Reinsurance Company"s Board of Management has resolved to buy back shares for a maximum total value of €1bn (excluding incidental expenses) in the period between 29 April 2022 and, at the latest, the Annual General Meeting on 5 May 2023. On the basis of the current share price (status: 21 February 2022), this would amount to around 2.8% of the share capital and correspond to 3.9 million own shares. The repurchased shares are to be retired. Together with the Board of Management"s dividend proposal to the Annual General Meeting of €11 per share, Munich Re"s capital repatriation thus totals €2.5bn. Contact: Dr. Stefan Gehring General Counsel & Group Chief Compliance Officer
|
Language: | English |
Company: | Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München |
Königinstraße 107 | |
80802 München | |
Germany | |
Phone: | +49(0) 89 3891-0 |
Fax: | +49(0) 89 399 056 |
E-mail: | shareholder@munichre.com |
Internet: | www.munichre.com |
ISIN: | DE0008430026, DE0008430026 |
WKN: | 843002, 843002 |
Indices: | DAX, EURO STOXX 50 |
Listed: | Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange; Mailand |
EQS News ID: | 1285635 |
End of Announcement | DGAP News Service |
1285635 22-Feb-2022 CET/CEST
Közzétételek - archívum
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. Enters into Strategic Partnership with U.S.-Israeli Cannabis Innovation Lab
[2020.07.22. 15:00]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. and Greek Joint Venture Partner to Launch "Cannamo(TM)" Brand of CBD Pet Products
[2020.07.08. 17:15]